Page last updated: 2024-08-23

paclitaxel and Cancer of the Uterus

paclitaxel has been researched along with Cancer of the Uterus in 127 studies

Research

Studies (127)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	20 (15.75)	18.2507
2000's	46 (36.22)	29.6817
2010's	48 (37.80)	24.3611
2020's	13 (10.24)	2.80

Authors

Authors	Studies
Chang, WH; Chen, YJ; Huang, HY; Lee, NR; Lin, SC; Su, MH; Wang, PH; Wu, HH	1
Bonamino, MH; Chaves, CBP; da Silva, JL; de Albuquerque, LZ; de Melo, AC; de Mesquita, GG; Rodrigues, FR	1
Copeland, LJ; DiSilvestro, PA; Filiaci, VL; Hensley, ML; Huang, HQ; Ioffe, OB; Miller, DS; Moore, KN; Mutch, DG; Powell, MA; Santin, A; Secord, AA; Spirtos, NM; Tewari, KS; Warshal, DP	1
Matei, D; Roque, DR	1
Wang, PH; Yang, ST	1
Cheng, Y; Sun, B; Wang, J; Zhao, N	1
Dasanu, CA; Farrell, S; Grover, M; Hwang, A; Iskandar, AS; Kerr, WT; Lerner, J; Ocampo, MM; Plaxe, SC	1
Economos, K; Friedman, M; Gorelick, C; Heyman, T; Kanis, MJ; Lee, YC; McEachron, J; Shanahan, L; Singhal, PK; Tran, V	1
Ebata, T; Fujiwara, K; Fujiwara, Y; Hasegawa, K; Kato, T; Nishikawa, T; Noguchi, E; Shimomura, A; Sudo, K; Tamura, K; Yonemori, K	1
Batman, S; Bohn, J; Bruegl, A; Caughey, A; Hersh, A; Weisenberger, MW; Winter, W	1
Almeida, A; Bartosch, C; Cruz Pires, M; Peixinho, C	1
Aoyama, Y; Harada, H; Hoshino, K; Kagami, S; Kinjo, Y; Kuradome, Y; Murakami, M; Ueda, T; Yoshino, K	1
Addis-Bernard, PJ; Alldredge, J; Bristow, RE; Cappuccini, F; Carioca, AAF; D'Amora, P; Evans, SS; Longoria, T; Marchioni, DML; Nagourney, RA; Palma, AM; Penner, KR; Salzgeber, MB; Silva, IDCG; Tewari, KS	1
Broadwater, G; Chino, JP; Foote, J; Gaillard, S; Havrilesky, LJ; Hong, JC	1
Armaiz-Pena, GN; Dalton, HJ; Dorniak, PL; Filant, J; Gharpure, KM; Haemmerle, M; Hansen, JM; Huang, J; Ivan, C; Linesch, SL; Lyons, Y; Mangala, LS; McGuire, MH; Nagaraja, AS; Noh, K; Pradeep, S; Previs, RA; Rupaimoole, R; Sood, AK; Wagner, MJ; Wu, SY	1
Allende, D; Fadare, O; Forscher, C; Roma, AA; Rutgers, JK	1
Asaka, M; Iwase, S; Kanno, M; Kato, H; Miyaji, T; Nomura, E; Ohba, Y; Ohnishi, S; Oyamada, S; Sakuragi, N; Sugiyama, T; Takeuchi, S; Uezono, Y; Watari, H; Yamaguchi, T	1
Fuh, KC; Guo, L; Hagemann, AR; Hagemann, IS; McCourt, CK; Mutch, DG; Palisoul, ML; Powell, MA; Quinn, JM; Reger, K; Schepers, E; Thaker, PH	1
Adachi, S; Baba, T; Blake, EA; Bush, SH; Hasegawa, K; Ikeda, Y; Im, DD; Iwasaki, K; Johnson, MS; Kelley, JL; Klobocista, MM; Machida, H; Matsuo, K; Miyake, TM; Nagano, T; Nishimura, M; Omatsu, K; Pejovic, T; Roman, LD; Ross, MS; Satoh, S; Shahzad, MMK; Shida, M; Takano, T; Takekuma, M; Takeuchi, S; Ueda, Y; Ueland, FR; Yanai, S; Yokoyama, T; Yunokawa, M	1
Ikeda, T; Kisu, I; Sakamoto, Y	1
Ishikawa, M; Kagawa, Y; Kawai, M; Maeda, T	1
Abdelghany, O; Azodi, M; Backes, F; Bellone, S; Buza, N; Celano, P; Chambers, SK; Edraki, B; ElSahwi, KS; Fader, AN; Havrilesky, L; Hui, P; Litkouhi, B; Lowery, W; Nevadunsky, N; O'Malley, DM; Pikaart, D; Ratner, E; Roque, DM; Santin, AD; Schwartz, PE; Secord, AA; Siegel, E; Silasi, DA	1
Einstein, MH; Frimer, M; Girda, E; Goldberg, GL; Kuo, DYS; Mehta, K; Miller, EM; Shankar, V; Smith, HO	1
Firuzi, O; Mostoufi, H; Tamaddon, AM; Yousefi, G	1
Kasahara, K; Nishi, K; Okazaki, A	1
Brown, SA; Linden, KM; Morgan, AB; Ostrovsky, O; Sookram, J; Zheng, A	1
Bryant, A; Das, N; Galaal, K; Godfrey, K; Kucukmetin, A; Lopes, AD; Naik, R; van der Heijden, E	1
Ayeni, TA; Bakkum-Gamez, JN; Dowdy, SC; Haddock, MG; Keeney, GL; Long, HJ; Mariani, A; McGree, ME; Podratz, KC; Weaver, AL	1
Azodi, M; Bellone, S; Bortolomai, I; Buza, N; Cocco, E; English, DP; Gasparrini, S; Ratner, E; Roque, DM; Rutherford, TJ; Santin, AD; Schwartz, PE; Silasi, DA	1
Altundağ, Ö; Ayhan, A; Dizdar, O; Dursun, P; Kucukoztas, N; Ozen, O; Rahatli, S; Reyhan, NH; Tarhan, C; Yalcin, S; Yildiz, F	1
Baba, T; Konishi, I; Mandai, M; Matsumura, N; Mikami, Y; Takamatsu, S	1
Fujimoto, T; Ito, K; Kagabu, M; Kigawa, J; Kurachi, H; Matsumoto, T; Mizunuma, H; Nagase, S; Nakahara, K; Niikura, H; Nishiyama, H; Otsuki, T; Sato, N; Sato, S; Shimada, M; Shoji, T; Soeda, S; Sugiyama, T; Takano, T; Tase, T; Terada, Y; Tokunaga, H; Toyoshima, M; Utsunomiya, H; Yaegashi, N; Yamada, H; Yokoyama, Y	1
Ditto, A; Lorusso, D; Mancini, M; Martinelli, F; Raspagliesi, F; Sarno, I	1
Ashton, E; Hoffman, J; Shafer, A; Szutowska, M	1
Arakawa, A; Futagami, M; Kamoi, S; Katabuchi, H; Katsuta, T; Kotera, K; Kudaka, W; Nishiyama, H; Nomura, H; Otsuki, A; Sato, N; Shibata, K; Shimada, M; Watanabe, Y; Yaegashi, N; Yokoyama, Y	1
Fujiwara, S; Kanemura, M; Ohmichi, M; Ono, YJ; Sasaki, H; Tanaka, T; Tanaka, Y; Terai, Y; Tsunetoh, S	1
Mahdi, H; Rizzo, A; Rose, PG	1
Dickson, EL; Dottino, J; Fader, AN; Gehrig, PA; Geller, MA; Havrilesky, L; Pierce, S; Ricci, S; Secord, AA; Vogel, RI	1
Jeong, K; Lee, SR; Park, S	1
Hazan, E; Sahu, J; Santa, E	2
Akkar, OB; Karadayi, K; Karakus, S; Kurt, A; Ugurlu, GP; Yanik, A; Yildiz, C	1
Economopoulos, T; Panayiotides, J; Papachristodoulou, A; Papaxoinis, G; Pectasides, D; Pectasides, E; Sykiotis, C; Tountas, N; Xiros, N	1
Abu-Rustum, NR; Aghajanian, CA; Alektiar, KM; Hensley, ML; Iasonos, A; Makker, V; Zhou, Q	1
Ali-Fehmi, R; Bryant, CS; Jelsema, J; Malone, JM; Shah, JP	1
Axtell, AE; Bottsford-Miller, J; Drake, RD; Fader, AN; Gehrig, PA; Gibbons, H; Havrilesky, LJ; Huh, WK; Kelley, JL; Moore, KN; Nagel, C; O'Malley, DM; Rose, PG; Secord, AA; Tuller, E; Walsh, CS; Zanotti, KM	1
Buttin, BM; Chapman-Davis, E; Hardt, JL; Hoekstra, AV; Kim, JJ; Morgan, J	1
Abulafia, O; Lee, YC; Salame, G; Wagreich, A	1
Bond, VK; Im, DD; Matsuo, K; Rosenshein, NB	1
Ahn, KS; Jeong, SJ; Jung, MH; Kim, SH; Lee, EO; Lee, HJ; Lee, SY; Rhee, YH	1
Degeest, K; Filiaci, VL; Hanjani, P; Mannel, RS; Miller, BE; Powell, MA; Rose, PG; Susumu, N; Ueland, FR	1
Fujimoto, H; Inatomi, S; Shimamoto, K; Sumioki, H	1
Bellone, M; Bellone, S; Casagrande, F; Cocco, E; Paik, D; Richter, CE; Rutherford, TJ; Santin, AD; Schwartz, PE; Siegel, EE	1
Bolz, K; Cheuk, R; Goh, J; Janda, M; Kondalsamy-Chennakesavan, S; Mileshkin, L; Nicklin, JL; Obermair, A; Perrin, LC; Sykes, P; Vasey, P; Wyld, D	1
Chen, D; Ding, LJ; Ren, XC; Teng, XD; Xia, AL; Xia, HP; Xu, ST; Xue, DB; Zhang, SJ	1
Atkinson, EN; Brown, J; Burke, TW; Coleman, RL; Euscher, E; Gano, JB; Lacour, RA; Ramirez, PT; Ramondetta, LM; Sun, CC	1
Choijamts, B; Emoto, M; Iwasaki, H; Jimi, S; Kondo, T; Kuroki, M; Matsumoto, T; Naganuma, Y	1
Berkowitz, R; Macklin, EA; Matulonis, U; Viswanathan, AN	1
Berman, ML; Dalmar, A; Lentz, SE; Mahdavi, A; Tajalli, TR; Vasilev, SA	1
Einstein, MH; Frimer, M; Goldberg, GL; Hou, JY; Huang, GS; Kuo, DY; Mehta, K; Mutyala, S; Reimers, LL	1
Hoshiai, H; Kotani, Y; Shiota, M; Tobiume, T; Umemoto, M	1
Bellone, S; Carrara, L; Emiliano, C; Guzzo, F; Pecorelli, S; Roque, DM; Rutherford, TJ; Santin, AD; Sartori, E; Schwartz, PE	1
Chang, CC; Wu, CC	1
Aynaoglu, G; Kahraman, K; Kankaya, D; Ortac, F	1
Aghajanian, C; Powell, MA; Secord, AA; Sill, MW; Steinhoff, M	1
Kang, S; Lim, MC; Lim, S; Park, JY; Park, SY; Seo, SS; Yoo, HJ	1
Cosio, S; Fuso, L; Gadducci, A; Landoni, F; Maggino, T; Sartori, E; Zola, P	1
Matsui, H; Sekiya, S; Yamazawa, K	1
Alvarez, RD; Kim, RY; Omura, GA	1
Imai, K; Mitsui, M; Takashi, K	1
Andersen, W; Blessing, JA; Gallup, DG; Morgan, MA	1
Gascón, P; Mármol, M; Mellado, B; Montagut, C; Ordi, J; Pahissa, J; Rey, V; Rovirosa, A	1
Anderson, P; Fields, A; Goldberg, G; Guha, C; Gupta, S; Jones, J; Khabele, D; Runowicz, C; Sood, BM; Vikram, B	1
Berkowitz, RS; Campos, SM; Duska, LR; Fuller, AF; Lee, H; Matulonis, UA; Penson, RT; Puchalski, TA; Seiden, MV; Supko, JG; Wilson, KS	1
Gehrig, PA; Moller, KA; Schorge, J; Secord, AA; Van Le, L	1
Beale, P; Carter, JR; Joshua, AM	1
Markman, M	2
Akahira, J; Ito, K; Matsunaga, G; Niikura, H; Tase, T; Toyoshima, M; Yaegashi, N	1
Covens, A; Gerulath, A; Merchandani, DE; Mirchandani, D; Osborne, R	1
Chew, SH; Chua, EJ; Low, J; Low, JS; Sethi, VK; Soh, LT; Tan, HS; Tay, EH; Wong, EH; Yap, SP	1
Fushiki, H; Ikoma, T; Ota, S; Yoshimoto, H	1
Hashimoto, H; Ishikawa, H; Nakajima, M; Niimi, S; Ohi, S; Okada, N; Sato, K; Tachibana, T; Tanaka, T; Yamada, K; Yasuda, M	1
Cibull, M; Cohn, D; DePriest, PD; Dietrich, CS; Gehrig, P; Giesler, J; Higgins, RV; Huh, W; Hunter, J; Kryscio, R; Manahan, K; Merritt, W; Modesitt, SC; Pavlik, EJ; Powell, M; Puls, L; Reedy, MB; Slomovitz, B; Ueland, FR; van Nagell, JR; Wilder, J	1
Amikura, T; Aoki, Y; Banzai, C; Nishikawa, N; Sekine, M; Suzuki, M; Tanaka, K; Yokoo, T	1
Arano Bermejo, JI; Cabañas Navarro, L; Capote Armas, LF; González-Palacios Martínez, F; Reguero Callejas, ME; Ruiz Tovar, J	1
Haruta, S; Kanayama, S; Kawaguchi, R; Kobayashi, H; Tanase, Y; Yamada, Y	1
Akizuki, K; Itoh, T; Kageyama, H; Minami, H; Nishida, T; Nishiyama, N; Ozaki, I; Ozuno, I; Shoji, S; Yamamoto, A; Yamamoto, K	1
Bitterman, P; Eaton, L; Filiaci, V; Homesley, HD; Kilgore, LC; Markman, M; Monk, BJ; Ueland, FR	1
Jobo, T	1
Ellard, S; Hoskins, PJ; Le, N; Lee, U; Martin, LA; Swenerton, KD; Tinker, AV	1
Bae, SN; Jung, SG; Kim, CJ; Kim, SJ; Lee, C; Na, YJ	1
Wang, HJ; Zheng, WX	1
Einstein, MH; Fields, AL; Gebb, J; Goldberg, GL; Novetsky, AP	1
Asselin, E; Gagnon, V; Leblanc, V; Turner, S; Van Themsche, C	1
Dowdy, SC; Madarek, EO; Mariani, A; Mutch, DG; Podratz, KC; Powell, MA; Thomas, M; Wright, JD	1
Abacioglu, U; Abdah-Bortnyak, R; Amit, A; Atahan, IL; Azria, D; Gold, DG; Goldberg, H; Kuten, A; Lavie, O; Meirovitz, A; Miller, RC; Ozsahin, M; Poortmans, PM; Steiner, M; Villà, S; Yildiz, F; Zidan, J	1
Haller, U; Koechli, OR; Perras, JP; Rodriguez, M; Schaer, GN; Schenk, V; Sevin, BU; Steren, A; Untch, M	1
Kavanagh, JJ; Kudelka, AP	1
Daxenbichler, G; Lang, T; Marth, C; Müller-Holzner, E; Widschwendter, M	1
Jones, WB; Lewis, JL; Schneider, J; Shapiro, F	1
Beketic-Oreskovic, L; Dumontet, C; Duran, GE; Sikic, BI; Steger, KA	1
Resnik, E; Taxy, JB	1
Edwards, CL; Kavanagh, JJ; Kudelka, AP; Lifshitz, S; Mante, RP; Piamsomboon, S; Termrungruanglert, W; Verschraegen, CF	1
Farghaly, SA	1
Ebbert, LP; Edmonson, JH; Gerstner, JB; Jung, SH; McGaw, H; Nascimento, AG	1
Edwards, CL; Kavanagh, JJ; Kudelka, AP; Termrungruanglert, W; Tornos, C; Vadhan-Raj, S; Varma, DG; Verschraegen, CF	1
Shimizu, Y	1
Del Carmen Bello, M; Gerson, R; Kavanagh, JJ; Kudelka, AP; Lazaro, M; Serrano, A	1
Diéras, V	1
Blaschke, TF; Duran, GE; Man, MC; Sikic, BI; Washington, CB	1
Burger, RA; Chen, L; Cheng, H; Khan, SA; Lincoln, AJ; Mallarino, MC; Monk, BJ; Zaunbrecher, GM	1
Amin, RM; Price, FV; Sumkin, J	1
DiSaia, PJ; Le, TD; Rutgers, JL; Yamada, SD	1
Belinson, JL; Kennedy, AW; Markman, M; Webster, KD; Zanotti, KM	1
Ball, H; Blessing, JA; Sutton, G	1
Hauns, B; Holländer, N; Maier-Lenz, H; Mross, K; Schumacher, M	1
Beketic-Oreskovic, L; Chen, GK; Durán, GE; Mangili, A; Sikic, BI	1
Carey, M; Winquist, E	1
Beijnen, JH; Duchin, K; Koopman, FJ; Lieverst, J; Malingré, MM; Rosing, H; Schellens, JH; Swart, M; ten Bokkel Huinink, WW; van Tellingen, O	1
Bevers, M; Bodurka-Bevers, D; Burke, TW; Gershenson, DM; Levenback, C; Ramondetta, L	1
Luker, KE; Pica, CM; Piwnica-Worms, D; Schreiber, RD	1
Blessing, JA; Curtin, JP; DeGeest, K; Soper, JT	1
Mortimer, JE; Picus, J; Read, WL	1
Fujimura, M; Fushiki, H; Izumi, R; Nakashima, A; Saito, S; Yuuki, H	1
Krauss, T	1
Aghajanian, C; Barakat, R; Geller, G; Hensley, ML; Lovegren, M; Maki, R; Sabbatini, P; Spriggs, DR; Tong, W; Venkatraman, E	1

Reviews

11 review(s) available for paclitaxel and Cancer of the Uterus

Article	Year
A review of basic to clinical targeted therapy and immunotherapy in uterine serous cancer. Molecular biology reports, 2023, Volume: 50, Issue:8 Topics: Carboplatin; Cystadenocarcinoma, Serous; Female; Humans; Immunotherapy; Paclitaxel; Tumor Microenvironment; Uterine Neoplasms	2023
Hypersensitivity Reaction to Carboplatin in Gynecologic Cancer: A Case Report and a Review of the Literature. Journal of UOEH, 2021, Volume: 43, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Drug Hypersensitivity; Drug Substitution; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome; Uterine Neoplasms	2021
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. The Cochrane database of systematic reviews, 2013, Feb-28, Issue:2 Topics: Antineoplastic Agents, Alkylating; Carcinosarcoma; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Paclitaxel; Radiotherapy; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Uterine Neoplasms	2013
Carboplatin and paclitaxel adjuvant chemotherapy in primitive neuroectodermal tumor of the uterine corpus. American journal of obstetrics and gynecology, 2009, Volume: 200, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Middle Aged; Neuroectodermal Tumors, Primitive; Paclitaxel; Postmenopause; Radiotherapy, Adjuvant; Uterine Hemorrhage; Uterine Neoplasms	2009
Advances in the treatment of gynecologic malignancies. Part 2: Cancers of the uterine corpus and ovary. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Female; Humans; Multicenter Studies as Topic; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Sarcoma; Uterine Neoplasms	2002
Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus. Gynecologic oncology, 2003, Volume: 90, Issue:2 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Mesonephroma; Neoplasm Recurrence, Local; Paclitaxel; Uterine Neoplasms	2003
The use of taxanes in choriocarcinoma; a case report and review of the literature. Gynecologic oncology, 2004, Volume: 94, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Female; Humans; Paclitaxel; Uterine Neoplasms	2004
[Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma in Situ; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Paclitaxel; Precancerous Conditions; Radiotherapy, Adjuvant; Uterine Neoplasms	2007
Systemic therapy for gynecologic cancer. Current opinion in oncology, 1993, Volume: 5, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytokines; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms	1993
[Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Ifosfamide; Mitomycin; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms; Vincristine	1997
[Update on gynecology]. Bulletin du cancer, 1998, Volume: 85, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Humans; Ovarian Neoplasms; Paclitaxel; Papillomaviridae; Uterine Neoplasms	1998

Trials

24 trial(s) available for paclitaxel and Cancer of the Uterus

Article	Year
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 03-20, Volume: 40, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Uterine Neoplasms	2022
Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02). Journal of gynecologic oncology, 2017, Volume: 28, Issue:5 Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drugs, Chinese Herbal; Female; Humans; Japan; Middle Aged; Nausea; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting	2017
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 07-10, Volume: 36, Issue:20 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Receptor, ErbB-2; Trastuzumab; Uterine Neoplasms	2018
Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Radiotherapy, Adjuvant; Survival Rate; Uterine Neoplasms	2018
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study. International journal of clinical oncology, 2014, Volume: 19, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Japan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Uterine Neoplasms; Uterus	2014
Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Combined Modality Therapy; Feasibility Studies; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Survival Rate; Uterine Neoplasms	2015
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-01, Volume: 28, Issue:16 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinosarcoma; Confidence Intervals; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Kaplan-Meier Estimate; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Probability; Prognosis; Program Evaluation; Risk Assessment; Survival Analysis; Treatment Outcome; Uterine Neoplasms	2010
Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecologic oncology, 2011, Volume: 120, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Paclitaxel; Prospective Studies; Quality of Life; Survival Analysis; Uterine Neoplasms	2011
A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Survival Rate; Treatment Outcome; Uterine Neoplasms	2011
Phase II trial of adjuvant pelvic radiation "sandwiched" between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma. Gynecologic oncology, 2012, Volume: 124, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Uterine Neoplasms	2012
Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study. Gynecologic oncology, 2012, Volume: 126, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Neoplasms	2012
Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma. Archives of gynecology and obstetrics, 2012, Volume: 286, Issue:6 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Sarcoma, Endometrial Stromal; Uterine Neoplasms	2012
Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 2003, Volume: 89, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Neoplasms	2003
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors. Gynecologic oncology, 2003, Volume: 90, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Drug Interactions; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Paclitaxel; Uterine Neoplasms	2003
Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma. Gynecologic oncology, 2005, Volume: 97, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant; Treatment Outcome; Uterine Neoplasms	2005
[A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Quality of Life; Uterine Cervical Neoplasms; Uterine Neoplasms	2005
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Feb-10, Volume: 25, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Uterine Neoplasms	2007
Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC). Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Pilot Projects; Prospective Studies; Uterine Neoplasms	2008
Phase II study of docetaxel in advanced soft tissue sarcomas. American journal of clinical oncology, 1996, Volume: 19, Issue:6 Topics: Adult; Aged; Alopecia; Anorexia; Antiemetics; Antineoplastic Agents, Phytogenic; Cause of Death; Dexamethasone; Diarrhea; Diphenhydramine; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leiomyosarcoma; Leukopenia; Male; Middle Aged; Nausea; Paclitaxel; Patient Selection; Premedication; Remission Induction; Sarcoma; Taxoids; Uterine Neoplasms; Vomiting	1996
Phase II trial of paclitaxel in leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 1999, Volume: 74, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Female; Humans; Leiomyosarcoma; Middle Aged; Paclitaxel; Uterine Neoplasms	1999
The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel. Anti-cancer drugs, 2001, Volume: 12, Issue:4 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Small Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Paclitaxel; Premedication; Stomach Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms	2001
Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecologic oncology, 2001, Volume: 82, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Papillary; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Rate; Uterine Neoplasms	2001
Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study. Gynecologic oncology, 2001, Volume: 83, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinosarcoma; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Uterine Neoplasms	2001
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jun-15, Volume: 20, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leiomyosarcoma; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome; Uterine Neoplasms	2002

Other Studies

92 other study(ies) available for paclitaxel and Cancer of the Uterus

Article	Year
Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma. Journal of the Chinese Medical Association : JCMA, 2022, 02-01, Volume: 85, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Female; Humans; Ifosfamide; Middle Aged; Paclitaxel; Platinum; Postoperative Period; Retrospective Studies; Uterine Neoplasms	2022
The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma. BMC cancer, 2021, Dec-07, Volume: 21, Issue:1 Topics: Aged; Antineoplastic Agents; B7-H1 Antigen; Biomarkers, Tumor; Carboplatin; Carcinosarcoma; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymphocytes, Tumor-Infiltrating; Middle Aged; Paclitaxel; Prevalence; Prognosis; Programmed Cell Death 1 Receptor; Signal Transduction; Tumor Microenvironment; Uterine Neoplasms	2021
Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022, 03-20, Volume: 40, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Paclitaxel; Uterine Neoplasms	2022
Abandon ifosfamide-based regimen and use paclitaxel-carboplatin regimen for the treatment of uterine carcinosarcoma. Journal of the Chinese Medical Association : JCMA, 2022, 05-01, Volume: 85, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Female; Humans; Ifosfamide; Paclitaxel; Uterine Neoplasms	2022
Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2020
Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020, Volume: 30, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinosarcoma; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Salpingo-oophorectomy; Survival Rate; Uterine Neoplasms	2020
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma. Oncology, 2020, Volume: 98, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Docetaxel; Doxorubicin; Female; Humans; Ifosfamide; Indazoles; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Progression-Free Survival; Pyrimidines; Retrospective Studies; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2020
Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis. Gynecologic oncology, 2021, Volume: 160, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Markov Chains; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Quality-Adjusted Life Years; Receptor, ErbB-2; Trastuzumab; United States; Uterine Neoplasms	2021
Placental site trophoblastic tumour: five challenges of patient clinical management. BMJ case reports, 2021, Jan-28, Volume: 14, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Consolidation Chemotherapy; Dactinomycin; Etoposide; Female; Humans; Hysterectomy; Lung Neoplasms; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Puerperal Disorders; Salpingectomy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms	2021
Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis. Gynecologic oncology, 2021, Volume: 163, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Metabolomics; Middle Aged; Ovarian Neoplasms; Paclitaxel; Uterine Neoplasms; Young Adult	2021
Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Paclitaxel; United States; Uterine Neoplasms	2017
Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies. Journal of the National Cancer Institute, 2017, 07-01, Volume: 109, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bevacizumab; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inhibitory Concentration 50; Kaplan-Meier Estimate; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Phosphoproteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Transcription Factors; Tumor Burden; Uterine Neoplasms; Xenograft Model Antitumor Assays; YAP-Signaling Proteins	2017
On Uterine Angiosarcomas: 2 Additional Cases. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2017, Volume: 36, Issue:4 Topics: Antineoplastic Agents; Carboplatin; Disease-Free Survival; Docetaxel; Fatal Outcome; Female; Hemangiosarcoma; Humans; Lung; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Paclitaxel; Uterine Neoplasms; Uterus	2017
Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer. Molecular cancer therapeutics, 2017, Volume: 16, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Cell Proliferation; Drug Synergism; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles; Uterine Neoplasms; Xenograft Model Antitumor Assays	2017
Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. Journal of surgical oncology, 2018, Volume: 117, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Case-Control Studies; Chemotherapy, Adjuvant; Cohort Studies; Disease-Free Survival; Female; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2018
[Safety Evaluation of Paclitaxel Injection NK in Tri-Weekly Administration of Paclitaxel plus Carboplatin(TC Therapy) for Gynecological Cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Uterine Neoplasms	2017
Prediction of neutrophil reduction using plasma paclitaxel concentration after administration in patients with uterine, ovarian, or cervical cancers in an outpatient clinic. Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Carboplatin; Cytochrome P-450 CYP3A; Female; Humans; Leukocyte Count; Middle Aged; Neutropenia; Neutrophils; Outpatients; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms	2018
Reversing multi-drug tumor resistance to Paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization. Colloids and surfaces. B, Biointerfaces, 2019, Feb-01, Volume: 174 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Membrane Permeability; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Hydrogen-Ion Concentration; Lysosomes; Paclitaxel; Peptide Fragments; Polymers; Tumor Cells, Cultured; Uterine Neoplasms	2019
Pseudo-Meigs syndrome caused by cancer of the uterine corpus. American journal of obstetrics and gynecology, 2019, Volume: 221, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carboplatin; Female; Humans; Hysterectomy; Meigs Syndrome; Neoplasms, Cystic, Mucinous, and Serous; Omentum; Paclitaxel; Pleural Effusion; Radiography, Thoracic; Salpingo-oophorectomy; Tomography, X-Ray Computed; Uterine Neoplasms	2019
Epigenetic therapy can inhibit growth of ovarian cancer cells and reverse chemoresistant properties acquired from metastatic omentum. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019, Volume: 145, Issue:2 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Female; Humans; Omentum; Ovarian Neoplasms; Paclitaxel; Pilot Projects; Uterine Neoplasms	2019
Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecologic oncology, 2013, Volume: 129, Issue:3 Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Neoplasms	2013
Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones. Cancer, 2013, Jul-15, Volume: 119, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Epothilones; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Paclitaxel; Platinum Compounds; Predictive Value of Tests; Prognosis; Real-Time Polymerase Chain Reaction; Tubulin; Tubulin Modulators; Up-Regulation; Uterine Neoplasms	2013
Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carboplatin; Carcinosarcoma; Cross-Linking Reagents; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Turkey; Uterine Neoplasms	2013
Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component. The journal of obstetrics and gynaecology research, 2014, Volume: 40, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinosarcoma; Chemotherapy, Adjuvant; Endometrium; Female; Humans; Hypercalcemia; Hysterectomy; Ovariectomy; Paclitaxel; Paraneoplastic Syndromes; Salpingectomy; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms; Uterus	2014
Carboplatin-Paclitaxel versus Cisplatin-Ifosfamide in the treatment of uterine carcinosarcoma: a retrospective cohort study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Female; Humans; Ifosfamide; Middle Aged; Paclitaxel; Retrospective Studies; Survival Analysis; Uterine Neoplasms	2014
Attempted conservative management of a placental site trophoblastic tumor: a case report. Connecticut medicine, 2014, Volume: 78, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lymph Node Excision; Methotrexate; Paclitaxel; Pregnancy; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine	2014
Genitofemoral neuropathy after pelvic lymphadenectomy in patients with uterine corpus cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carboplatin; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hysterectomy; Incidence; Laparoscopy; Lymph Node Excision; Middle Aged; Ovariectomy; Paclitaxel; Pelvis; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Recovery of Function; Salpingectomy; Sensation Disorders; Time Factors; Uterine Neoplasms	2015
Outcome of recurrent uterine papillary serous carcinoma treated with platinum-based chemotherapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Papillary; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Cystic, Mucinous, and Serous; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Neoplasms	2015
A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma. Gynecologic oncology, 2015, Volume: 139, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Uterine Neoplasms	2015
A Rare Case of Intra-Endometrial Leiomyoma of Uterus Simulating Degenerated Submucosal Leiomyoma Accompanied by a Large Sertoli-Leydig Cell Tumor. Yonsei medical journal, 2016, Volume: 57, Issue:2 Topics: Adenomyosis; Carboplatin; Female; Humans; Laparoscopy; Leiomyoma; Male; Menorrhagia; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Sertoli-Leydig Cell Tumor; Treatment Outcome; Uterine Neoplasms	2016
Diffuse Rash After the Administration of Carboplatin and Paclitaxel. The American Journal of dermatopathology, 2016, Volume: 38, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinosarcoma; Drug Eruptions; Eczema; Exanthema; Female; Humans; Middle Aged; Paclitaxel; Skin; Uterine Neoplasms	2016
Diffuse Rash After the Administration of Carboplatin and Paclitaxel: Answer. The American Journal of dermatopathology, 2016, Volume: 38, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinosarcoma; Drug Eruptions; Eczema; Exanthema; Female; Humans; Middle Aged; Paclitaxel; Skin; Uterine Neoplasms	2016
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for gynecological malignancies: a single center experience. European journal of gynaecological oncology, 2016, Volume: 37, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cohort Studies; Cytoreduction Surgical Procedures; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Sarcoma; Survival Rate; Treatment Outcome; Uterine Neoplasms; Young Adult	2016
Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution. Gynecologic oncology, 2008, Volume: 110, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Polyethylene Glycols; Retrospective Studies; Survival Rate; Uterine Neoplasms	2008
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma. Gynecologic oncology, 2008, Volume: 111, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Disease-Free Survival; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2008
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Cystadenocarcinoma, Serous; Disease Progression; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2009
Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma. Gynecologic oncology, 2009, Volume: 114, Issue:2 Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Papillary; Cell Growth Processes; Cell Line, Tumor; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; gamma-Synuclein; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Neoplasm Proteins; Paclitaxel; RNA, Small Interfering; Transfection; Uterine Neoplasms	2009
Advanced ovarian carcinoma following bilateral uterine artery embolization: a case report. The Journal of reproductive medicine, 2009, Volume: 54, Issue:5 Topics: Carcinoma, Papillary; Cisplatin; Female; Humans; Leiomyoma; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Uterine Artery Embolization; Uterine Neoplasms	2009
Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay. American journal of clinical oncology, 2010, Volume: 33, Issue:4 Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinosarcoma; Cisplatin; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Taxoids; Uterine Neoplasms	2010
Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells. Environmental toxicology, 2011, Volume: 26, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cinchona Alkaloids; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Paclitaxel; Quinidine; Sarcoma; Uterine Neoplasms	2011
[A case of metastatic choriocarcinoma responding to combination chemotherapy with paclitaxel and carboplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Lung Neoplasms; Middle Aged; Paclitaxel; Pregnancy; Remission Induction; Tomography, X-Ray Computed; Uterine Neoplasms	2010
Higher sensitivity to patupilone versus paclitaxel chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro. Gynecologic oncology, 2010, Volume: 119, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Papillary; Cell Line, Tumor; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epothilones; Female; Humans; Paclitaxel; Receptor, ErbB-2; Tubulin; Uterine Neoplasms	2010
[Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2010, Volume: 39, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Survival Rate; Uterine Neoplasms	2010
CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor). Stem cells (Dayton, Ohio), 2011, Volume: 29, Issue:10 Topics: AC133 Antigen; Animals; Antigens, CD; Antigens, Neoplasm; Carcinosarcoma; Cell Adhesion Molecules; Cell Differentiation; Cell Line, Tumor; Cell Separation; Cell Transformation, Neoplastic; Cisplatin; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Estrogen Receptor beta; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Homeodomain Proteins; Humans; Immunohistochemistry; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mixed Tumor, Mullerian; Nanog Homeobox Protein; Neoplastic Stem Cells; Octamer Transcription Factor-3; Paclitaxel; PAX2 Transcription Factor; Peptides; SOXB1 Transcription Factors; Uterine Neoplasms; Vimentin; Wnt4 Protein	2011
The importance of chemotherapy and radiation in uterine papillary serous carcinoma. Gynecologic oncology, 2011, Volume: 123, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Serous; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Retrospective Studies; Survival Rate; Uterine Neoplasms	2011
Role of adjuvant chemotherapy in patients with early stage uterine papillary serous cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:8 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; California; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2011
Incidental detection of breast apocrine carcinoma via endometrial cytology. The Tohoku journal of experimental medicine, 2011, Volume: 225, Issue:4 Topics: Apocrine Glands; Breast Neoplasms; Carcinoma; Endometrium; Female; Humans; Laparotomy; Lymph Node Excision; Mastectomy, Modified Radical; Middle Aged; Paclitaxel; Uterine Neoplasms	2011
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression. Gynecologic oncology, 2012, Volume: 125, Issue:1 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinosarcoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Epothilones; Female; Humans; Inhibitory Concentration 50; Middle Aged; Ovarian Neoplasms; Paclitaxel; Real-Time Polymerase Chain Reaction; Tubulin; Uterine Neoplasms	2012
Beau's lines. QJM : monthly journal of the Association of Physicians, 2013, Volume: 106, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Female; Humans; Ifosfamide; Middle Aged; Nail Diseases; Paclitaxel; Pigmentation Disorders; Renal Dialysis; Uterine Neoplasms	2013
Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report. Taiwanese journal of obstetrics & gynecology, 2012, Volume: 51, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Chemotherapy, Adjuvant; Chordoma; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Paclitaxel; Sacrococcygeal Region; Uterine Neoplasms	2012
Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Postoperative Complications; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Treatment Failure; Uterine Neoplasms; Young Adult	2012
Gastric perforation induced by combination chemotherapy in a patient with long-term use of corticosteroids. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2002, Volume: 78, Issue:2 Topics: Adenocarcinoma; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cisplatin; Female; Humans; Intestinal Perforation; Middle Aged; Paclitaxel; Prednisolone; Taxoids; Time Factors; Uterine Neoplasms	2002
[Practical use of taxol-based chemotherapy for poor compliance gynecologic cancers in Japanese woman]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Compliance; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Quality of Life; Uterine Cervical Neoplasms; Uterine Neoplasms	2003
Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. International journal of radiation oncology, biology, physics, 2003, Sep-01, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Papillary; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Shiga Toxins; Survival Analysis; Treatment Failure; Uterine Neoplasms	2003
The role of optimal debulking in advanced stage serous carcinoma of the uterus. Gynecologic oncology, 2004, Volume: 94, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Neoplasms	2004
Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal? Journal of cancer research and clinical oncology, 2004, Volume: 130, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Patient Selection; Quality of Life; Treatment Outcome; Uterine Neoplasms	2004
Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. Gynecologic oncology, 2004, Volume: 94, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Clinical Trials as Topic; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2004
Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet. The Journal of reproductive medicine, 2004, Volume: 49, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Salvage Therapy; Uterine Neoplasms	2004
Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH--special reference to the susceptibility of anti-cancer drugs. Human cell, 2004, Volume: 17, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Uterine Neoplasms; Vinblastine	2004
The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Gynecologic oncology, 2005, Volume: 99, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Uterine Neoplasms	2005
Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO. Gynecologic oncology, 2006, Volume: 102, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Liver Neoplasms; Lung Diseases, Interstitial; Lung Neoplasms; Methotrexate; Paclitaxel; Uterine Neoplasms; Vincristine	2006
Malignant mixed Mullerian tumors. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Hysterectomy; Ifosfamide; Ilium; Middle Aged; Mixed Tumor, Mullerian; Neoplasms, Second Primary; Ovariectomy; Paclitaxel; Palliative Care; Pelvic Neoplasms; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Spinal Neoplasms; Uterine Neoplasms	2006
[Adjuvant chemotherapy of paclitaxel plus carboplatin in uterine corpus cancer--comparison with cisplatin, adriamycin plus cyclophosphamide]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Hysterectomy; Middle Aged; Neutropenia; Paclitaxel; Survival Rate; Thrombocytopenia; Uterine Neoplasms	2006
[Metastatic lung tumor from uterine leiomyosarcoma]. Kyobu geka. The Japanese journal of thoracic surgery, 2006, Volume: 59, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Combined Modality Therapy; Female; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pneumonectomy; Uterine Neoplasms	2006
[Outpatient chemotherapy in gynecologic oncology]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 2 Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Irinotecan; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms	2006
Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Neoplasms	2008
Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience. The Journal of reproductive medicine, 2007, Volume: 52, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cisplatin; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Korea; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Salvage Therapy; Severity of Illness Index; Uterine Neoplasms	2007
Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis : an international journal on programmed cell death, 2008, Volume: 13, Issue:2 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Doxorubicin; Female; HeLa Cells; Humans; Paclitaxel; Proto-Oncogene Proteins c-akt; Uterine Neoplasms; X-Linked Inhibitor of Apoptosis Protein	2008
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review. Gynecologic oncology, 2008, Volume: 108, Issue:2 Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Neoplasms	2008
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecologic oncology, 2008, Volume: 108, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Uterine Neoplasms	2008
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms. Anti-cancer drugs, 1995, Volume: 6, Issue:1 Topics: Adenosine Triphosphate; Adult; Antineoplastic Agents; Choriocarcinoma; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Hydatidiform Mole; Paclitaxel; Pregnancy; Trophoblastic Neoplasms; Tumor Cells, Cultured; Uterine Neoplasms; Vincristine	1995
Effects of Taxol on choriocarcinoma cells. American journal of obstetrics and gynecology, 1995, Volume: 173, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Choriocarcinoma; Chorionic Gonadotropin; Cycloheximide; Etoposide; Female; Humans; Methotrexate; Paclitaxel; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms	1995
Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecologic oncology, 1996, Volume: 61, Issue:1 Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Frontal Lobe; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Paclitaxel; Platinum; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine	1996
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer research, 1996, Mar-01, Volume: 56, Issue:5 Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Drug Resistance; Female; Humans; Molecular Sequence Data; Mutation; Paclitaxel; Sarcoma; Tubulin; Tumor Cells, Cultured; Uterine Neoplasms	1996
Neoadjuvant chemotherapy in uterine papillary serous carcinoma. Gynecologic oncology, 1996, Volume: 62, Issue:1 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Female; Humans; Paclitaxel; Uterine Neoplasms	1996
Remission of refractory gestational trophoblastic disease with high-dose paclitaxel. Anti-cancer drugs, 1996, Volume: 7, Issue:5 Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Female; Granulocyte Colony-Stimulating Factor; Humans; Paclitaxel; Pregnancy; Remission Induction; Trophoblastic Neoplasms; Uterine Neoplasms	1996
A possible chemotherapeutic response by paclitaxel and other antineoplastic agents in treatment of choriocarcinoma in vitro. American journal of obstetrics and gynecology, 1996, Volume: 175, Issue:4 Pt 1 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Choriocarcinoma; Female; Humans; Paclitaxel; Pregnancy; Tumor Cells, Cultured; Uterine Neoplasms	1996
Remission of advanced uterine leiomyosarcoma with pulmonary metastases with carboplatin and paclitaxel. Anti-cancer drugs, 1996, Volume: 7, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Drug Therapy, Combination; Female; Humans; Leiomyosarcoma; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Tomography, X-Ray Computed; Uterine Neoplasms	1996
Response of choriocarcinoma to paclitaxel. Case report and review of resistance. European journal of gynaecological oncology, 1997, Volume: 18, Issue:2 Topics: Adult; Antineoplastic Agents, Phytogenic; Choriocarcinoma; Drug Resistance, Neoplasm; Female; Humans; Paclitaxel; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms	1997
Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Nov-01, Volume: 19, Issue:3 Topics: Anti-HIV Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HIV Protease Inhibitors; Humans; Indinavir; Leukemia, Erythroblastic, Acute; Nelfinavir; Paclitaxel; Ritonavir; Saquinavir; Sarcoma; Tumor Cells, Cultured; Uterine Neoplasms; Vinblastine	1998
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitro. Gynecologic oncology, 1999, Volume: 72, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Blotting, Western; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; In Vitro Techniques; Isoenzymes; Paclitaxel; Protein Kinase C; Sarcoma; Signal Transduction; Tumor Cells, Cultured; Uterine Neoplasms	1999
Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma. Gynecologic oncology, 1999, Volume: 73, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel; Uterine Neoplasms	1999
Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin. Gynecologic oncology, 1999, Volume: 73, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cystadenocarcinoma, Papillary; Female; Humans; Neoplasm Staging; Paclitaxel; Remission Induction; Uterine Neoplasms	1999
The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. Gynecologic oncology, 1999, Volume: 74, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Cisplatin; Cystadenocarcinoma, Papillary; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Survival Rate; Uterine Neoplasms	1999
The pharmacokinetics of a 1-h paclitaxel infusion. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Uterine Neoplasms	2000
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells. British journal of cancer, 2000, Volume: 83, Issue:7 Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Paclitaxel; Phenotype; Rhodamine 123; RNA, Messenger; Sarcoma; Tritium; Tumor Cells, Cultured; Uterine Neoplasms; Vault Ribonucleoprotein Particles; Vinblastine	2000
Activity of docetaxel in chemoresistant gestational choriocarcinoma. Gynecologic oncology, 2000, Volume: 79, Issue:3 Topics: Adult; Antineoplastic Agents, Phytogenic; Choriocarcinoma; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Paclitaxel; Pregnancy; Taxoids; Uterine Neoplasms	2000
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer research, 2001, Sep-01, Volume: 61, Issue:17 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Interferon Type I; Interferon-Stimulated Gene Factor 3; Interferon-Stimulated Gene Factor 3, gamma Subunit; Microtubules; Paclitaxel; Signal Transduction; Transcription Factors; Transfection; Tumor Cells, Cultured; Uterine Neoplasms; Vinblastine	2001
Severe interstitial pneumonitis associated with docetaxel administration. Cancer, 2002, Feb-01, Volume: 94, Issue:3 Topics: Adrenal Cortex Hormones; Aged; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Fatal Outcome; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Paclitaxel; Prognosis; Prostatic Neoplasms; Respiration, Artificial; Taxoids; Uterine Neoplasms	2002
[Apoptosis as a measure of chemosensitivity to anti-cancer drugs in gynecological cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; In Situ Nick-End Labeling; Irinotecan; Mice; Mice, Nude; Mitomycin; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured; Uterine Neoplasms	2002
[Certified study protocols for patients with endometrial carcinoma]. Zentralblatt fur Gynakologie, 2002, Volume: 124, Issue:1 Topics: Clinical Trials as Topic; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germany; Humans; Multicenter Studies as Topic; Paclitaxel; Taxoids; Uterine Neoplasms	2002
Ethical difficulties with randomized clinical trials involving cancer patients: examples from the field of gynecologic oncology. The Journal of clinical ethics, 1992,Fall, Volume: 3, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Ethics, Medical; Female; Humans; Nontherapeutic Human Experimentation; Ovarian Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Risk Assessment; Therapeutic Human Experimentation; Uncertainty; Uterine Neoplasms	1992